Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. (9th December 2013)

• Record Type: Journal Article
• Authors: Davis, A.; Dobson, R.; Kaninia, S.; Espasandin, M.; Berg, A.; Giovannoni, G.; Schmierer, K.
• Is Part Of: European journal of neurology. Volume 21:Number 2(2014:Feb.)
• Page Start: 305
• Page End: 311
• Publication Date: 2013-12-09
• Subjects: Neurology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ene.12307
• Languages: English
• ISSNs: 1351-5101

Abstract

<abstract abstract-type="main" id="ene12307-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ene12307-sec-0001" sec-type="section"> <title>Background and purpose</title> <p>Lumbar puncture (LP) is a key diagnostic procedure in medicine. Post lumbar puncture headache (PLPHA) is a well recognized complication of LP. Evidence suggests that using atraumatic needles for diagnostic LP (ATNLP) reduces risk of PLPHA. However, clinicians in Europe and the USA routinely use traumatic needles for diagnostic LP (TNLP). The occurrence of PLPHA following ATNLP and TNLP was compared in a clinical setting. Further, a survey was performed exploring use of ATNLP amongst UK neurologists.</p> </sec> <sec id="ene12307-sec-0002" sec-type="section"> <title>Methods</title> <p>Service development study. Patients were followed up 2 and 7 days after LP using blinded telephone assessment. A questionnaire was developed to assess use of ATNLP amongst UK neurologists. Frequency, onset, duration and severity of PLPHA were recorded as were use of analgesia, general practitioner consultations, hospital readmissions, days off work due to PLPHA and cost. Neurologists were asked about their familiarity with, and use of, ATNLP.</p> </sec> <sec id="ene12307-sec-0003" sec-type="section"> <title>Results</title> <p>One hundred and nine participants attending the Royal London Hospital were included, and 74 attendees of the Association of British Neurologists 2012 conference completed an on‐site questionnaire. ATNLP reduced the rate of PLPHA (27.1% vs. 60.4%; <italic>P </italic><<italic> </italic>0.01). In those participants who developed PLPHA symptoms were short lived (mean 50 h vs. 94 h, <italic>P </italic>=<italic> </italic>0.02) and less severe after ATNLP. Use of ATNLP led to significant cost savings. Only one in five UK neurologists regularly use ATNLP stating lack of training and availability of atraumatic needles as main reasons.</p> </sec> <sec id="ene12307-sec-0004" sec-type="section"> <title>Conclusions</title> <p>ATNLP significantly reduces the risk of PLPHA. Training is required 3 to facilitate a change from TNLP to ATNLP amongst clinicians.</p> </sec> </abstract>